A blood test conducted in a prehospital setting may rapidly distinguish between ischemic and hemorrhagic stroke, potentially facilitating more rapid, targeted treatment. The test measures the levels ...
PRAGUE, Czech Republic — A 0.4-mg/kg bolus dose of tenecteplase (TNKase, Genentech) was associated with functional outcomes and safety similar to those seen with the standard of care, alteplase ...
An ultra-sensitive blood test that reflects brain damage after acute ischemic stroke - and also predicts functional outcome. This is a discovery that is expected to be of great significance in the ...
Mobile stroke units (MSUs) are ambulances with staff and a computed tomographic scanner that may enable faster treatment with tissue plasminogen activator (t-PA) than standard management by emergency ...
A decade ago, at age 55, Don Lewis suffered a stroke in his sleep. When he woke up, he couldn’t move his left arm or leg. Lewis’ neighbor realized his truck hadn’t moved in two days and called 911 for ...
Objectives This study assessed whether a previously developed Monte Carlo simulation model can be reused for evaluating various strategies to minimise time-to-treatment in southwest Netherlands for ...
Consent is an important consideration if introducing testing. A patient expert highlighted that people who have had a stroke often have severe cognitive impairment, may have difficulty with their ...
The role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations. We conducted a multicenter, prospective, open-label, randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results